Chemoinformaics analysis of .alpha.-Kessyl alcohol
| Molecular Weight | 238.371 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
| Exact Molecular Weight | 238.193 | nRing | 4 |
| Solubility: LogS | -3.328 | nHRing | 2 |
| Solubility: LogP | 3.33 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.9906 |
| nHD | 1 | BPOL | 27.8194 |
| QED | 0.703 |
| Synth | 5.255 |
| Natural Product Likeliness | 3.559 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.611 |
| MDCK | 0.0000223 |
| BBB | 0.871 |
| PPB | 0.894994 |
| VDSS | 1.536 |
| FU | 0.119383 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.543 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.934 |
| CYP2c9-inh | 0.128 |
| CYP2c9-sub | 0.367 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.593 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.478 |
| CL | 14.333 |
| T12 | 0.202 |
| hERG | 0.019 |
| Ames | 0.016 |
| ROA | 0.095 |
| SkinSen | 0.043 |
| Carcinogencity | 0.147 |
| EI | 0.063 |
| Respiratory | 0.877 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.86888 |